Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndrome

British Journal of Dermatology

Volumn 164, Issue 4, 2011, Pages 886-888

  Khunger, N ^a   Pahwa, M ^a  

^a SAFDARJUNG HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TIMOLOL;

ARTERY MALFORMATION; CAPILLARY HEMANGIOMA; CASE REPORT; CHILD; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EYE EXAMINATION; FEMALE; HEMANGIOMA; HUMAN; INFANT; LETTER; NEUROLOGIC EXAMINATION; OPHTHALMOSCOPY; POSTERIOR FOSSA; PRESCHOOL CHILD; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TREATMENT RESPONSE;

ABNORMALITIES, MULTIPLE; ADMINISTRATION, TOPICAL; ADRENERGIC BETA-AGONISTS; FACIAL NEOPLASMS; FEMALE; HEMANGIOMA; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; SYNDROME; TIMOLOL; TREATMENT OUTCOME;

EID: 79953691119     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10177.x     Document Type: Letter

References (11)

1. Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects and eye abnormalities. Arch Dermatol 1996; 132:307-11. (Pubitemid 26085184)
2. Khunger N. Vascular anomalies in the neonate: dilemmas in management. J Neonatol 2008; 22:41-8.
3. Williams EF III, Stanislaw P, Dupree M et al. Hemangiomas in infants and children. An algorithm for intervention. Arch Facial Plast Surg 2000; 2:103-11.
4. Dinehart SM, Kincannon J, Geronemus R. Hemangiomas: evaluation and treatment. Dermatol Surg 2001; 27:475-85. (Pubitemid 32436341)
5. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358:2649-51. (Pubitemid 351831393)
6. Manunza F, Syed S, Laguda B et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants. Br J Dermatol 2010; 162:466-8.
7. Guo S, Ni N. Topical treatment for capillary hemangioma of the eye-lid using beta-blocker solution. Arch Ophthalmol 2010; 128:255-6.
8. Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010; 146:564-5.
9. D'Angelo G, Lee H, Weiner RI. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 1997; 67:353-66. (Pubitemid 27509471)
10. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action. Br J Dermatol 2010; 163:269-74.
11. Zimmerman TJ, Kooner KS, Morgan KS. Safety and efficacy of timolol in pediatric glaucoma. Surv Ophthalmol 1983; 28:262-4.